This chart is intended to compare and contrast in summary form some of the considerations for a private company considering merging into an existing public operating company in a reverse merger or entering into a business combination with a special purpose acquisition company (“SPAC”). In particular, reverse mergers into operating companies with failed clinical programs have become common for private life sciences companies as an alternative to undertaking traditional IPOs.
Please see full publication below for more information.
